Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Ardelyx Inc’s stock clocked out at $4.19, up 7.44% from its previous closing price of $3.9. In other words, the price has increased by $7.44 from its previous closing price. On the day, 8.04 million shares were traded. ARDX stock price reached its highest trading level at $4.3399 during the session, while it also had its lowest trading level at $3.91.
Ratios:
To gain a deeper understanding of ARDX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.81 and its Current Ratio is at 4.12. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 1.06.
On May 02, 2025, Raymond James Downgraded its rating to Outperform which previously was Strong Buy but kept the price unchanged to $11.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 16 ’25 when MOTT DAVID M bought 200,000 shares for $3.63 per share. The transaction valued at 725,880 led to the insider holds 2,896,871 shares of the business.
MOTT DAVID M bought 200,000 shares of ARDX for $737,260 on Jun 09 ’25. The Director now owns 2,696,871 shares after completing the transaction at $3.69 per share. On May 20 ’25, another insider, Williams Laura A, who serves as the Chief Medical Officer of the company, sold 6,421 shares for $4.08 each. As a result, the insider received 26,207 and left with 402,583 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ARDX now has a Market Capitalization of 1002478528 and an Enterprise Value of 905558400. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.77 while its Price-to-Book (P/B) ratio in mrq is 6.88. Its current Enterprise Value per Revenue stands at 2.504 whereas that against EBITDA is -24.219.
Stock Price History:
The Beta on a monthly basis for ARDX is 0.68, which has changed by -0.2079395 over the last 52 weeks, in comparison to a change of 0.1185931 over the same period for the S&P500. Over the past 52 weeks, ARDX has reached a high of $7.18, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is 4.90%, while the 200-Day Moving Average is calculated to be -17.37%.
Shares Statistics:
It appears that ARDX traded 5.49M shares on average per day over the past three months and 4334700 shares per day over the past ten days. A total of 239.20M shares are outstanding, with a floating share count of 230.36M. Insiders hold about 3.72% of the company’s shares, while institutions hold 71.17% stake in the company. Shares short for ARDX as of 1749772800 were 27283637 with a Short Ratio of 4.97, compared to 1747267200 on 27769893. Therefore, it implies a Short% of Shares Outstanding of 27283637 and a Short% of Float of 12.920000000000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
